» Articles » PMID: 36743661

Severe Acute Respiratory Syndrome Coronavirus 2 May Cause Liver Injury Na/H Exchanger

Overview
Journal World J Virol
Date 2023 Feb 6
PMID 36743661
Authors
Affiliations
Soon will be listed here.
Abstract

The liver has many significant functions, such as detoxification, the urea cycle, gluconeogenesis, and protein synthesis. Systemic diseases, hypoxia, infections, drugs, and toxins can easily affect the liver, which is extremely sensitive to injury. Systemic infection of severe acute respiratory syndrome coronavirus 2 can cause liver damage. The primary regulator of intracellular pH in the liver is the Na/H exchanger (NHE). Physiologically, NHE protects hepatocytes from apoptosis by making the intracellular pH alkaline. Severe acute respiratory syndrome coronavirus 2 increases local angiotensin II levels by binding to angiotensin-converting enzyme 2. In severe cases of coronavirus disease 2019, high angi-otensin II levels may cause NHE overstimulation and lipid accumulation in the liver. NHE overstimulation can lead to hepatocyte death. NHE overstimulation may trigger a cytokine storm by increasing proinflammatory cytokines in the liver. Since the release of proinflammatory cytokines such as interleukin-6 increases with NHE activation, the virus may indirectly cause an increase in fibrinogen and D-dimer levels. NHE overstimulation may cause thrombotic events and systemic damage by increasing fibrinogen levels and cytokine release. Also, NHE overstimulation causes an increase in the urea cycle while inhibiting vitamin D synthesis and gluconeogenesis in the liver. Increasing NHE3 activity leads to Na loading, which impairs the containment and fluidity of bile acid. NHE overstimulation can change the gut microbiota composition by disrupting the structure and fluidity of bile acid, thus triggering systemic damage. Unlike other tissues, tumor necrosis factor-alpha and angiotensin II decrease NHE3 activity in the intestine. Thus, increased luminal Na leads to diarrhea and cytokine release. Severe acute respiratory syndrome coronavirus 2-induced local and systemic damage can be improved by preventing virus-induced NHE overstimulation in the liver.

References
1.
Campello E, Bulato C, Spiezia L, Boscolo A, Poletto F, Cola M . Thrombin generation in patients with COVID-19 with and without thromboprophylaxis. Clin Chem Lab Med. 2021; 59(7):1323-1330. DOI: 10.1515/cclm-2021-0108. View

2.
Ilias I, Diamantopoulos A, Botoula E, Athanasiou N, Zacharis A, Tsipilis S . Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients. Front Endocrinol (Lausanne). 2021; 12:644055. PMC: 8242942. DOI: 10.3389/fendo.2021.644055. View

3.
Martineau A, Cantorna M . Vitamin D for COVID-19: where are we now?. Nat Rev Immunol. 2022; 22(9):529-530. PMC: 9305676. DOI: 10.1038/s41577-022-00765-6. View

4.
Huang C, Cogan M, Cragoe Jr E, IVES H . Thrombin activation of the Na+/H+ exchanger in vascular smooth muscle cells. Evidence for a kinase C-independent pathway which is Ca2+-dependent and pertussis toxin-sensitive. J Biol Chem. 1987; 262(29):14134-40. View

5.
Rother N, Yanginlar C, Lindeboom R, Bekkering S, van Leent M, Buijsers B . Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons. Cell Rep Med. 2020; 1(9):100146. PMC: 7762774. DOI: 10.1016/j.xcrm.2020.100146. View